These results indicate that reducing the expression level of SHMT2 leads to a decrease in the proportion of cells in the G0/G1 phase and an arrest of the cell cycle in the G2/M phase in bladder cancer cells J82 and T24. Here, SHMT2 is linked to urinary bladder cancer.